LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics experienced significant selling activity recently, with RA Capital Management disposing of over 9 million dollars in shares. This follows a period where the stock price declined by nearly 35 percent over the last quarter. No executive purchases occurred during this timeframe, contrasting with previous internal buying patterns observed earlier in the year.
Ticker: LENZ Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for LENZ Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
George Jeffrey P. Non-Executive Director
Transaction date
Purchase
Price
8.92
Quantity 5,592 New position
Value US$49,890
3.0
Chevallard Daniel R. Chief Financial Officer Officer
Transaction date
Purchase
Price
8.57
Quantity 7,500 +139.2%
Value US$64,275
1.4
Schimmelpennink Evert B. President, CEO and Secretary Executive Director
Transaction date
Purchase
Price
8.95
Quantity 28,089 +57.1%
Value US$251,411
Olsson Shawn Chief Commercial Officer Officer
Transaction date
Planned sale
Price
26.37
Quantity 5,788 -55.0%
Value US$152,612
Olsson Shawn Chief Commercial Officer Officer
Transaction date
Planned sale
Price
25.74
Quantity 4,212 -28.6%
Value US$108,411
SHAWN OLSSON Officer Officer
Transaction date
Proposed sale
Price
25.60
Quantity 40,000
Value US$1,024,000
3.4
MCCOLLUM JAMES W Non-Executive Director
Transaction date
Purchase
Price
22.79
Quantity 10,500 New position
Value US$239,278
3.0
Chevallard Daniel R. Chief Financial Officer Officer
Transaction date
Purchase
Price
22.76
Quantity 2,178 +67.9%
Value US$49,563
3.0
Chevallard Daniel R. Chief Financial Officer Officer
Transaction date
Purchase
Price
22.71
Quantity 20 +0.6%
Value US$454
3.0
Chevallard Daniel R. Chief Financial Officer Officer
Transaction date
Purchase
Price
15.68
Quantity 3,188 New position
Value US$49,988
3.0
Chevallard Daniel R. Chief Financial Officer Officer
Transaction date
Purchase
Price
15.68
Quantity 3,188 New position
Value US$49,988
3.4
MCCOLLUM JAMES W Non-Executive Director
Transaction date
Purchase
Price
15.99
Quantity 31,332 +6.3%
Value US$501,093
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.03
Quantity 64,971 +10.3%
Value US$976,514
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.03
Quantity 933,038 +39.1%
Value US$14,023,561
1.7
Samsara BioCapital, L.P. Large shareholder
Transaction date
Purchase
Price
4.08
Quantity 350,000 +4.3%
Value US$1,428,000
Gutry Phil CHIEF BUSINESS OFFICER Officer
Transaction date
Planned purchase
Price
4.01
Quantity 5,000 +1.7%
Value US$20,050
1.7
Samsara BioCapital, L.P. Large shareholder
Transaction date
Purchase
Price
8.99
Quantity 100,000 +1.3%
Value US$899,000
1.7
Samsara BioCapital, L.P. Large shareholder
Transaction date
Purchase
Price
10.19
Quantity 22,329 +0.3%
Value US$227,533
1.7
Samsara BioCapital, L.P. Large shareholder
Transaction date
Purchase
Price
10.15
Quantity 201,685 +2.7%
Value US$2,047,103
1.7
Samsara BioCapital, L.P. Large shareholder
Transaction date
Purchase
Price
13.22
Quantity 45,400 +0.6%
Value US$600,188
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-02 2026-10-29 S Sale Large shareholder
92,386 +7.7%
114.64
US$3,069,223
92,386 +7.7% 114.64 US$3,069,223
2026-11-02 2026-10-29 S Sale Large shareholder
82,188 +29.4%
160.10
US$2,943,632
82,188 +29.4% 160.10 US$2,943,632
2026-11-02 2026-10-29 S Sale Large shareholder
25,817 -5.8%
453.56
US$1,167,833
25,817 -5.8% 453.56 US$1,167,833
2026-03-30 2026-03-27 B Purchase Non-Executive Director
5,592 New position
8.92
US$49,890
5,592 New position 8.92 US$49,890
2026-03-30 2026-03-27 B Purchase

Chief Financial Officer

Officer
7,500 +139.2%
8.57
US$64,275
7,500 +139.2% 8.57 US$64,275
2026-03-30 2026-03-27 B Purchase

President, CEO and Secretary

Executive Director
28,089 +57.1%
8.95
US$251,411
28,089 +57.1% 8.95 US$251,411
2025-11-19 2025-11-17 PlS Planned sale

Chief Commercial Officer

Officer
5,788 -55.0%
26.37
US$152,612
5,788 -55.0% 26.37 US$152,612
2025-11-19 2025-11-17 PlS Planned sale

Chief Commercial Officer

Officer
4,212 -28.6%
25.74
US$108,411
4,212 -28.6% 25.74 US$108,411
2025-11-17 2025-11-17 PrS Proposed sale

Officer

Officer
40,000
25.60
US$1,024,000
40,000 25.60 US$1,024,000
2025-11-10 2025-11-07 B Purchase Non-Executive Director
10,500 New position
22.79
US$239,278
10,500 New position 22.79 US$239,278
2025-11-07 2025-11-07 B Purchase

Chief Financial Officer

Officer
2,178 +67.9%
22.76
US$49,563
2,178 +67.9% 22.76 US$49,563
2025-11-07 2025-11-07 B Purchase

Chief Financial Officer

Officer
20 +0.6%
22.71
US$454
20 +0.6% 22.71 US$454
2025-10-02 2025-09-30 S Sale Large shareholder
123 -0.0%
47.01
US$5,783
123 -0.0% 47.01 US$5,783
2025-10-02 2025-09-30 S Sale Large shareholder
177 -0.0%
47.01
US$8,321
177 -0.0% 47.01 US$8,321
2025-10-02 2025-09-30 S Sale Large shareholder
57,502 -7.0%
46.41
US$2,668,484
57,502 -7.0% 46.41 US$2,668,484
2025-10-02 2025-09-30 S Sale Large shareholder
83,066 -7.3%
46.41
US$3,854,827
83,066 -7.3% 46.41 US$3,854,827
2025-10-02 2025-09-30 S Sale Large shareholder
34,405 -4.0%
45.35
US$1,560,428
34,405 -4.0% 45.35 US$1,560,428
2025-10-02 2025-09-30 S Sale Large shareholder
49,701 -4.2%
45.35
US$2,254,174
49,701 -4.2% 45.35 US$2,254,174
2025-09-22 2025-09-18 S Sale Large shareholder
132 -0.0%
43.30
US$5,716
132 -0.0% 43.30 US$5,716
2025-09-22 2025-09-18 S Sale Large shareholder
268 -0.0%
43.30
US$11,604
268 -0.0% 43.30 US$11,604
2025-09-22 2025-09-18 S Sale Large shareholder
20,148 -2.3%
43.00
US$866,441
20,148 -2.3% 43.00 US$866,441
2025-09-22 2025-09-18 S Sale Large shareholder
40,907 -3.3%
43.00
US$1,759,156
40,907 -3.3% 43.00 US$1,759,156
2025-09-22 2025-09-18 S Sale Large shareholder
24,370 -2.7%
41.59
US$1,013,568
24,370 -2.7% 41.59 US$1,013,568
2025-09-22 2025-09-18 S Sale Large shareholder
49,479 -3.9%
41.59
US$2,057,871
49,479 -3.9% 41.59 US$2,057,871
2025-08-26 2025-08-26 S Sale Large shareholder
1,707 -0.2%
39.50
US$67,430
1,707 -0.2% 39.50 US$67,430
2025-08-26 2025-08-26 S Sale Large shareholder
3,465 -0.3%
39.50
US$136,875
3,465 -0.3% 39.50 US$136,875
2025-08-26 2025-08-26 S Sale Large shareholder
21,661 -2.3%
38.97
US$844,224
21,661 -2.3% 38.97 US$844,224
2025-08-26 2025-08-26 S Sale Large shareholder
43,978 -3.3%
38.97
US$1,714,016
43,978 -3.3% 38.97 US$1,714,016
2025-08-26 2025-08-25 S Sale Large shareholder
1,058 -0.1%
39.92
US$42,237
1,058 -0.1% 39.92 US$42,237
2025-08-26 2025-08-25 S Sale Large shareholder
2,149 -0.2%
39.92
US$85,791
2,149 -0.2% 39.92 US$85,791
2025-08-26 2025-08-25 S Sale Large shareholder
24,760 -2.6%
39.53
US$978,651
24,760 -2.6% 39.53 US$978,651
2025-08-26 2025-08-25 S Sale Large shareholder
50,270 -3.7%
39.53
US$1,986,947
50,270 -3.7% 39.53 US$1,986,947
2025-08-26 2025-08-22 S Sale Large shareholder
2,809 -0.3%
40.59
US$114,017
2,809 -0.3% 40.59 US$114,017
2025-08-26 2025-08-22 S Sale Large shareholder
5,668 -0.4%
40.59
US$230,064
5,668 -0.4% 40.59 US$230,064
2025-08-26 2025-08-22 S Sale Large shareholder
10,076 -1.0%
40.03
US$403,339
10,076 -1.0% 40.03 US$403,339
2025-08-26 2025-08-22 S Sale Large shareholder
20,493 -1.5%
40.03
US$820,329
20,493 -1.5% 40.03 US$820,329
2025-08-19 2025-08-18 S Sale Large shareholder
15,085 -1.5%
38.56
US$581,694
15,085 -1.5% 38.56 US$581,694
2025-08-19 2025-08-18 S Sale Large shareholder
30,628 -2.1%
38.56
US$1,181,049
30,628 -2.1% 38.56 US$1,181,049
2025-08-19 2025-08-15 S Sale Large shareholder
69,949 -6.7%
39.50
US$2,762,986
69,949 -6.7% 39.50 US$2,762,986
2025-08-19 2025-08-15 S Sale Large shareholder
145,051 -9.2%
39.50
US$5,729,514
145,051 -9.2% 39.50 US$5,729,514
2025-07-14 2025-07-10 S Sale Large shareholder
191,376 -10.8%
34.00
US$6,506,784
191,376 -10.8% 34.00 US$6,506,784
2025-07-01 2025-06-27 S Sale Large shareholder
200,000 -10.2%
30.47
US$6,093,000
200,000 -10.2% 30.47 US$6,093,000
2025-06-20 2025-06-20 S Sale Large shareholder
133,924 -6.4%
30.25
US$4,051,201
133,924 -6.4% 30.25 US$4,051,201
2025-06-20 2025-06-20 S Sale Large shareholder
100,877 -8.8%
30.35
US$3,061,617
100,877 -8.8% 30.35 US$3,061,617
2025-06-20 2025-06-18 S Sale Large shareholder
100,000 -8.0%
29.95
US$2,995,000
100,000 -8.0% 29.95 US$2,995,000
2025-06-12 2025-06-10 S Sale Large shareholder
350,000 -21.9%
29.00
US$10,150,000
350,000 -21.9% 29.00 US$10,150,000
2024-05-15 2024-05-14 B Purchase

Chief Financial Officer

Officer
3,188 New position
15.68
US$49,988
3,188 New position 15.68 US$49,988
2024-05-15 2024-05-14 B Purchase

Chief Financial Officer

Officer
3,188 New position
15.68
US$49,988
3,188 New position 15.68 US$49,988
2024-05-14 2024-05-13 B Purchase Non-Executive Director
31,332 +6.3%
15.99
US$501,093
31,332 +6.3% 15.99 US$501,093
2024-03-25 2024-03-21 B Purchase Non-Executive Director Large shareholder
64,971 +10.3%
15.03
US$976,514
64,971 +10.3% 15.03 US$976,514
2024-03-25 2024-03-21 B Purchase Non-Executive Director Large shareholder
933,038 +39.1%
15.03
US$14,023,561
933,038 +39.1% 15.03 US$14,023,561
2022-04-13 2022-04-12 B Purchase Large shareholder
350,000 +4.3%
4.08
US$1,428,000
350,000 +4.3% 4.08 US$1,428,000
2022-04-13 2022-04-11 PP Planned purchase

CHIEF BUSINESS OFFICER

Officer
5,000 +1.7%
4.01
US$20,050
5,000 +1.7% 4.01 US$20,050
2022-04-13 2022-04-11 B Purchase Large shareholder
74,464 +0.9%
4.07
US$303,068
74,464 +0.9% 4.07 US$303,068
2022-01-25 2022-01-24 B Purchase Large shareholder
23,000 +0.3%
8.70
US$200,100
23,000 +0.3% 8.70 US$200,100
2022-01-25 2022-01-21 B Purchase Large shareholder
100,000 +1.3%
8.99
US$899,000
100,000 +1.3% 8.99 US$899,000
2022-01-21 2022-01-20 B Purchase Large shareholder
43,105 +0.5%
8.92
US$384,497
43,105 +0.5% 8.92 US$384,497
2022-01-21 2022-01-19 B Purchase Large shareholder
54,565 +0.7%
9.24
US$504,181
54,565 +0.7% 9.24 US$504,181
2021-12-20 2021-12-15 B Purchase Large shareholder
22,329 +0.3%
10.19
US$227,533
22,329 +0.3% 10.19 US$227,533
2021-11-24 2021-11-22 B Purchase Large shareholder
201,685 +2.7%
10.15
US$2,047,103
201,685 +2.7% 10.15 US$2,047,103
2021-10-15 2021-10-15 B Purchase Large shareholder
2,300 +0.0%
12.49
US$28,727
2,300 +0.0% 12.49 US$28,727
2021-10-15 2021-10-14 B Purchase Large shareholder
3,100 +0.0%
12.50
US$38,750
3,100 +0.0% 12.50 US$38,750
2021-10-15 2021-10-13 B Purchase Large shareholder
45,400 +0.6%
13.22
US$600,188
45,400 +0.6% 13.22 US$600,188
2021-10-08 2021-10-08 B Purchase Large shareholder
75,000 +1.0%
13.12
US$984,000
75,000 +1.0% 13.12 US$984,000
2021-10-08 2021-10-07 B Purchase Large shareholder
9,021 +0.1%
14.94
US$134,774
9,021 +0.1% 14.94 US$134,774
2021-10-08 2021-10-06 B Purchase Large shareholder
61,475 +0.8%
13.83
US$850,199
61,475 +0.8% 13.83 US$850,199